Am Fam Physician. 2016 Oct 1;94(7):551-557.
Author disclosure: No relevant financial affiliations.
Several mosquito-borne viral infections have recently emerged in North America; West Nile virus is the most common in the United States. Although West Nile virus generally causes a self-limited, flulike febrile illness, a serious neuroinvasive form may occur. Dengue is the most common vector-borne viral disease worldwide, and it has been a significant public health threat in the United States since 2009. Known as breakbone fever for its severe myalgias and arthralgias, dengue may cause a hemorrhagic syndrome. Chikungunya also causes flulike febrile illness and disabling arthralgias. Although meningoencephalitis may occur with chikungunya, bleeding is uncommon. Symptoms of Zika virus infection are similar to those of dengue, but milder. Zika virus increases the risk of fetal brain abnormalities, including microcephaly, if a pregnant woman is infected. Zika virus is spread through Aedes albopictus mosquito bites, is transmitted sexually, and may rarely spread nonsexually from person to person. Diagnosis of these vector-borne infections is clinical and serologic, and treatment is supportive. Other, well-established vector-borne diseases are also important. Ehrlichiosis is a tick-borne bacterial disease that presents as a nonspecific syndrome of fever, headache, malaise, and myalgias. It is diagnosed via blood smear testing, with confirmatory serology. Ehrlichiosis is treated with doxycycline. Rickettsial infections are transmitted by fleas, mites, and ticks, and severity ranges from mild to life threatening. Rocky Mountain spotted fever, the most significant rickettsial infection, is primarily a clinical diagnosis that presents as fever, headache, myalgias, petechial rash, and tick exposure. Doxycycline is effective for rickettsial infections if administered promptly. Vector avoidance strategies are critical to the prevention of all of these infections.
Vector-borne diseases are infections that are primarily or exclusively transmitted through an invertebrate, generally insects.1 Some pathogens undergo an obligate stage of their life cycle inside the vector; others use the vector only for transport and inoculation. The most common vector-borne diseases are carried through mosquitoes and ticks. Vector-borne diseases account for 17% of all infections worldwide.1 The main impact of these diseases occurs abroad,1 but they are becoming more common in North America. Table 1 and Table 2 summarize common vector-borne diseases.
WHAT IS NEW ON THIS TOPIC: VECTOR-BORNE DISEASES
All pregnant women with a history of travel to a Zika virus outbreak area are advised to undergo viral testing and fetal ultrasonography.
Men with confirmed Zika virus infection should abstain from sexual intercourse or use condoms for six months after the onset of infection.
Men who have traveled to areas of Zika virus transmission but have no known infection should abstain from sexual intercourse or use condoms for at least six months after departure from the area.
Rare nonsexual, person-to-person transmission of Zika virus has been reported.
SORT: KEY RECOMMENDATIONS FOR PRACTICE
|Clinical recommendation||Evidence rating||References||Comments|
Women who are pregnant or potentially pregnant should avoid travel to areas where Zika virus is spreading. If they choose to travel to these areas, mosquito avoidance measures should be taken.
Although malformation and microcephaly are associated with Zika virus infection, the risk of acquiring an infection when bitten by an infected mosquito and the risk of adverse fetal effects if infected are unknown.
Men with confirmed Zika virus infection should abstain from sexual intercourse or use condoms for six months after the onset of infection. Men who have traveled to areas of Zika virus transmission but have no known infection should abstain from sexual intercourse or use condoms for at least six months after departure from the area.
Doxycycline is the drug of choice for rickettsial infections, even in children younger than eight years.
Benefit outweighs risk
Insect repellents with DEET 20% to 50% are effective for the prevention of many vector-borne diseases. Other agents such as picaridin, IR3535, and oil of lemon eucalyptus also appear to be effective.
Use in conjunction with physical barriers and other arthropod avoidance measures.
Insecticide-impregnated bed nets are effective for the prevention of mosquito-borne disease in endemic areas.
Significant benefit in decreasing incidence of malaria, a mosquito-borne infection
DEET = diethyltoluamide.
A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to http://www.aafp.org/afpsort.
SORT: KEY RECOMMENDATIONS FOR PRACTICE
|Clinical recommendation||Evidence rating||References||Comments|
Women who are pregnant or potentially pregnant should avoid travel to
REFERENCESshow all references
1. World Health Organization. Vector-borne diseases. February 2016. http://www.who.int/mediacentre/factsheets/fs387/en/. Accessed February 12, 2016....
2. Vora N. Impact of anthropogenic environmental alterations on vector-borne diseases. Medscape J Med. 2008;10(10):238.
3. Lindsey NP, Lehman JA, Staples JE, Fischer M. West Nile virus and other nationally notifiable arboviral diseases - United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(34):929–934.
4. Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA. 2013;310(3):308–315.
5. World Health Organization. Dengue. http://www.who.int/topics/dengue/en/. Accessed July 27, 2016.
6. Adams D, Fullerton K, Jajosky R, et al. Summary of notifiable infectious diseases and conditions - United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;62(53):1–122.
7. Johnston D, Viray M, Ushiroda J, et al.; Hawaii Dengue Response Team. Notes from the field: outbreak of locally acquired cases of dengue fever—Hawaii, 2015. MMWR Morb Mortal Wkly Rep. 2016;65(2):34–35.
8. Thiberville SD, Moyen N, Dupuis-Maguiraga L, et al. Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res. 2013;99(3):345–370.
9. Centers for Disease Control and Prevention. Chikungunya virus. Geographic distribution. http://www.cdc.gov/chikungunya/geo/index.html. Accessed February 11, 2016.
10. Lee VJ, Chow A, Zheng X, et al. Simple clinical and laboratory predictors of chikungunya versus dengue infections in adults. PLoS Negl Trop Dis. 2012;6(9):e1786.
11. World Health Organization. Guidelines on clinical management of chikungunya fever. October 2008. http://www.wpro.who.int/mvp/topics/ntd/Clinical_Mgnt_Chikungunya_WHO_SEARO.pdf. Accessed July 8, 2016.
12. Hennessey M, Fischer M, Staples JE. Zika virus spreads to new areas - region of the Americas, May 2015–January 2016. MMWR Morb Mortal Wkly Rep. 2016;65(3):55–58.
13. Centers for Disease Control and Prevention. Zika virus. Advice for people living in or traveling to Wynwood, a neighborhood in Miami, FL. http://www.cdc.gov/zika/intheus/florida-update.html. Accessed August 9, 2016.
14. Dirlikov E, Ryff KR, Torres-Aponte J, et al. Update: ongoing Zika virus transmission - Puerto Rico, November 1, 2015–April 14, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(17):451–455.
15. Centers for Disease Control and Prevention. All countries and territories with active Zika virus transmission. July 2016. http://www.cdc.gov/zika/geo/active-countries.html. Accessed July 21, 2016.
16. Fleming-Dutra KE, Nelson JM, Fischer M, et al. Update: interim guidelines for health care providers caring for infants and children with possible Zika virus infection - United States, February 2016. MMWR Morb Mortal Wkly Rep. 2016;65(7):182–187.
17. Mlakar J, Korva M, Tul N, et al. Zika virus associated with microcephaly. N Engl J Med. 2016;374(10):951–958.
18. Martines RB, Bhatnagar J, Keating MK, et al. Notes from the field: evidence of Zika virus infection in brain and placental tissues from two congenitally infected newborns and two fetal losses—Brazil, 2015. MMWR Morb Mortal Wkly Rep. 2016;65(6):159–160.
19. Pacheco O, Beltrán M, Nelson CA, et al. Zika virus disease in Colombia – preliminary report [published ahead of print June 15, 2016]. N Engl J Med. http://www.nejm.org/doi/full/10.1056/NEJMoa1604037. Accessed July 11, 2016.
20. Centers for Disease Control and Prevention. Pregnant women: how to protect yourself. 2016. http://www.cdc.gov/zika/pregnancy/protect-yourself.html#one. Accessed July 8, 2016.
21. Oduyebo T, Petersen EE, Rasmussen SA, et al. Update: interim guidelines for health care providers caring for pregnant women and women of reproductive age with possible Zika virus exposure - United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(5):122–127.
22. Oster AM, Brooks JT, Stryker JE, et al. Interim guidelines for prevention of sexual transmission of Zika virus - United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(5):120–121.
23. Deckard DT, Chung WM, Brooks JT, et al. Male-to-male sexual transmission of Zika virus - Texas, January 2016. MMWR Morb Mortal Wkly Rep. 2016;65(14):372–374.
24. Oster AM, Russell K, Stryker JE, et al. Update: interim guidance for prevention of sexual transmission of Zika virus - United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(12):323–325.
25. Davidson A, Slavinski S, Komoto K, Rakeman J, Weiss D. Suspected female-to-male sexual transmission of Zika virus—New York City, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(28):716–717.
26. Centers for Disease Control and Prevention. CDC assisting Utah investigation of Zika virus infection apparently not linked to travel. July 2016. http://www.cdc.gov/media/releases/2016/s0718-zika-utah-investigation.html. Accessed July 21, 2016.
27. Interim guidance for Zika virus testing of urine - United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(18):474.
28. Rabe IB, Staples JE, Villanueva J, et al. Interim guidance for interpretation of Zika virus antibody test results. MMWR Morb Mortal Wkly Rep. 2016;65(21):543–546.
29. Nichols HK, Dahlgren FS, Drexler NA, Massung RF, Behravesh CB. Increasing incidence of ehrlichiosis in the United States: a summary of national surveillance of Ehrlichia chaffeensis and Ehrlichia ewingii infections in the United States, 2008–2012. Am J Trop Med Hyg. 2016;94(1):52–60.
30. Ganguly S, Mukhopadhayay SK. Tick-borne ehrlichiosis infection in human beings. J Vector Borne Dis. 2008;45(4):273–280.
31. Drexler NA, Dahlgren FS, Heitman KN, Massung RF, Paddock CD, Behravesh CB. National surveillance of spotted fever group rickettsioses in the United States, 2008–2012. Am J Trop Med Hyg. 2016;94(1):26–34.
32. Walker DH. Changing dynamics of human-rickettsial interactions. Am J Trop Med Hyg. 2016;94(1):3–4.
33. Chen LF, Sexton DJ. What's new in Rocky Mountain spotted fever? Infect Dis Clin North Am. 2008;22(3):415–432.
34. Buckingham SC. Tick-borne diseases of the USA: ten things clinicians should know. J Infect. 2015;71(suppl 1):S88–S96.
35. Woodhall D, Jones JL, Cantey PT, Wilkins PP, Montgomery SP. Neglected parasitic infections: what every family physician needs to know. Am Fam Physician. 2014;89(10):803–811.
36. Johnson BA, Kalra MG. Prevention of malaria in travelers [published correction appears in Am Fam Physician. 2012;86(3):222.]. Am Fam Physician. 2012;85(10):973–977.
37. Wright WF, Riedel DJ, Talwani R, Gilliam BL. Diagnosis and management of Lyme disease. Am Fam Physician. 2012;85(11):1086–1093.
38. Yates J. Advice for protection against mosquitoes and ticks. Am Fam Physician. 2015;91(11):754–755.
39. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev. 2004;(2):CD000363.
Copyright © 2016 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions